MYX mayne pharma group limited

Some Analysis, page-12

  1. 335 Posts.
    lightbulb Created with Sketch. 266
    Not quite correct..Patrick. At 70c exchange rate and annualised it's A$70.8

    Third Quarter 2022 Financial Results and Business Highlights



    Three Months Ended September 30,

    Nine Months Ended September 30,



    2022

    2021

    2022

    2021

    Product revenue:







    ANNOVERA

    $

    10,415


    $

    11,807


    $

    37,196


    $

    30,112

    IMVEXXY

    6,947


    8,016


    20,583


    24,866

    BIJUVA

    2,663


    3,298


    7,877


    7,899

    Prescription vitamin

    892


    1,335


    2,671


    4,162

    Product revenue, net

    20,917


    24,456


    68,327


    67,039

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.03
Change
-0.170(3.27%)
Mkt cap ! $408.6M
Open High Low Value Volume
$5.20 $5.21 $5.03 $2.804M 555.6K

Buyers (Bids)

No. Vol. Price($)
2 14654 $5.03
 

Sellers (Offers)

Price($) Vol. No.
$5.14 3111 2
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.